Details of Drug-Metabolizing Enzyme (DME)
General Information of Drug-Metabolizing Enzyme (DME) (ID: DER0XCH)
DME Name | Farnesol dehydrogenase (AKR1B15) | ||||
---|---|---|---|---|---|
Synonyms | Aldo-keto reductase family 1 member B15; Testosterone 17beta-dehydrogenase; Estradiol 17-beta-dehydrogenase AKR1B15; AKR1B15 | ||||
Gene Name | AKR1B15 | ||||
UniProt ID | |||||
INTEDE ID | |||||
3D Structure | |||||
Gene ID | |||||
EC Number | EC: 1.1.1.54 | ||||
Lineage | Species: Homo sapiens | ||||
Sequence |
MATFVELSTKAKMPIVGLGTWRSLLGKVKEAVKVAIDAEYRHIDCAYFYENQHEVGEAIQ
EKIQEKAVMREDLFIVSKVWPTFFERPLVRKAFEKTLKDLKLSYLDVYLIHWPQGFKTGD DFFPKDDKGNMISGKGTFLDAWEAMEELVDEGLVKALGVSNFNHFQIERLLNKPGLKYKP VTNQVECHPYLTQEKLIQYCHSKGITVTAYSPLGSPDRPWAKPEDPSLLEDPKIKEIAAK HKKTTAQVLIRFHIQRNVTVIPKSMTPAHIVENIQVFDFKLSDEEMATILSFNRNWRAFD FKEFSHLEDFPFDAEY |
||||
Function |
This enzyme catalyzes the NADPH-dependent reduction of a variety of carbonyl substrates, like aromatic aldehydes, alkenals, ketones and alpha-dicarbonyl compounds. In addition, it catalyzes the reduction of androgens and estrogens with high positional selectivity (shows 17-beta- hydroxysteroid dehydrogenase activity) as well as 3-keto-acyl-CoAs. It displays strong enzymatic activity toward all-trans- retinal and 9-cis-retinal and may play a physiological role in retinoid metabolism.
|
||||
Reactome Pathway | |||||
Molecular Interaction Atlas (MIA) of This DME
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3 Approved Drug(s) Metabolized by This DME
|
||||||||||||||||||||||||||||||||||||||||
1 Clinical Trial Drug(s) Metabolized by This DME
|
||||||||||||||||||||||||||||||||||||||||
1 Investigative Drug(s) Metabolized by This DME
|
||||||||||||||||||||||||||||||||||||||||
Experimental Enzyme Kinetic Data of Drugs |
|
|||||||||||||||||||||||||||||||||||||||
References